Increased IL-4 production in response to virulent Mycobacterium tuberculosis in tuberculosis patients with advanced disease;Aumento da produção de IL-4: Resposta ao Mycobacterium tuberculosis virulento em doentes com tuberculose em estádio avançado

Acta Medica Portuguesa

Volumn 18, Issue 1, 2005, Pages 27-36

  Ordway, Diane J ^a   Martins, Marta S ^a   Costa, Leonor M ^a   Freire, Mónica S ^a   Arroz, Maria J ^a   Dockrell, Hazel M ^a   Ventura, Fernando A ^a  

^a NONE

Author keywords

Interferon ; Interleukins; Lymphocyte proliferation; Tuberculosis (TB)

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 4; INTERLEUKIN 5; MYCOBACTERIUM ANTIGEN; T LYMPHOCYTE RECEPTOR; TUBERCULIN;

ARTICLE; BACTERIAL COUNT; BACTERIAL VIRULENCE; CELL CULTURE; CLINICAL ARTICLE; COCULTURE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNE STATUS; LUNG PARENCHYMA; LYMPHOCYTE PROLIFERATION; MYCOBACTERIUM TUBERCULOSIS; MYCOBACTERIUM TUBERCULOSIS H37RV; PERIPHERAL BLOOD MONONUCLEAR CELL; SPUTUM EXAMINATION; T LYMPHOCYTE SUBPOPULATION; TUBERCULOSIS;

ADULT; ANTIGENS, BACTERIAL; DISEASE PROGRESSION; HUMANS; INTERLEUKIN-4; MYCOBACTERIUM TUBERCULOSIS; TUBERCULOSIS; VIRULENCE;

EID: 22144468448     PISSN: None     EISSN: 16460758     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. BOAVENTURA JL: Os números da tuberculose: aspectos epidemiológicos actuais. Inform SIDA e Outr Doen Infecc 1999; 16:28-9.
2. RAVIGLIONE MC, RIEDER HL, STYBLO K, KHOMENKO AG, ESTEVES K, KOCHI A: Tuberculosis trends in Eastern Europe and the former USSR. Tuberc Lung Dis 1994; 75:400-16.
3. RAVIGLIONE MC, SUDRE P, RIEDER HL, SPINACI S, KOCHI A: Secular trends of tuberculosis in Western Europe. Bull WHO 1993; 71:297-306.
4. RIEDER HL, ZELLWEGER JP, RAVIGLIONE MC, KEIZER ST, MIGLIORI GB: Tuberculosis control in Europe and international migration. Eur Respir J 1994; 7:1545-53.
5. MOSMANN TR, SAD S: The expanding universe of T-cell subsets: Th1, Th2 and more. Immunol Today 1996; 17:138-46.
6. LIN Y, ZHANG MF, HOFMAN FM, GONG J, BARNES PF: Absence of a prominent Th2 cytokine response in human tuberculosis. Infect Immun 1996; 64:1351-56.
7. SURCEL HM, TROYE-BLOMBERG M, PAULIE S et al: Th1/Th2 profiles in tuberculosis, based on the proliferation and cytokine response of blood lymphocytes to mycobacterial antigens. Immunol 1994; 81:171-76.
8. BHATTACHARYYA S, SINGLA R, DEY AB, PRASAD HK: Dichotomy of cytokine profiles in patients and high-risk healthy subjects exposed to tuberculosis Infect Immun 1999; 67:5597-5603.
9. SMITH SM, DOCKRELL HM: Role of CD8+ T cells in mycobacterial infections. Immunol Cell Biol 2000; 78:325-33.
10. DAS G, VORHA B, SAHA B, AGREWALA JN, MISHRA GC: Apoptosis of Th1-like cells in experimental tuberculosis (TB). Clin Exp Immunol 1999; 115:324-28.
11. JOHNSON BJ, MCMURRAY DN: Cytokine gene expression by culture of human lymphocytes with autologous Mycobacterium tuberculosis-infected monocytes. Infect Immun 1994; 62:1444-50.
12. SANCHEZ FO, RODRIGUEZ JI, AGUDELO G, GARCIA LF: Immune responsiveness and lymphokine production in patients with tuberculosis and healthy controls. Infect Immun 1994; 62:5673-78.
13. ZHANG M, GONG J, PRESKY DH, XUE W, BARNES PF: Expression of the IL-12 receptor beta 1 and beta 2 subunits in human tuberculosis. J Immunol 1999; 162:2441-47.
14. VAN CREVEL R, KARYADI E, PREYERS F, et al: Increased production of interleukin 4 by CD4+ and CD8+ T cells from patients with tuberculosis is related to the presence of pulmonary cavities. J Infect Dis 2000; 181:1194-97.
15. FENHALLS G, STEVENS L, BEZUIDENHOUT J, et al: Distribution of IFN-gamma, IL-4 and TNF-alpha protein and CD8 T cells producing IL-12p40 mRNA in human lung tuberculosis granulomas. Immunol 2002; 105:325-35.
16. COOPER AM, DALTON DK, STEWART TA, GRIFFIN JP, RUSSELL DG, ORME IM: Disseminated tuberculosis in interferon gamma gene-disrupted mice. J Exp Med 1993; 178:2243-47.
17. FLYNN JL, CHAN J, TRIEBOLD KJ, DALTON SK, STEWART TA, BLOOM BR: An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection. J Exp Med 1993; 178:2249-54
18. KAMIJO R, LE J, SHAPIRO D et al: Mice that lack the interferon-gamma receptor have profoundly altered responses to infection with Bacillus Calmette-Guerin and subsequent challenge with lipopolysaccharide. J Exp Med 1993; 178:1435-40.
19. KUMARARATNE DS: Tuberculosis and immunodeficiency-of mice and men. Clin Exp Immunol 1997; 107:11-14.
20. International Chronic Granulomatous Disease Cooperative Study. A controlled trial of interferon gamma to prevent infections in Chronic Granulomatous Disease. New Engl J Med 1991; 324:509-16.
21. HO JL, HE SH, RIOS MJC, WICK EA: Interleukin-4 inhibits human macrophage activation by tumor necrosis factor, granulocyte-monocyte colony stimulating factor, and interleukin-3 for antileishmanial activity and oxidative burst capacity. J Infect Dis 1992; 165:344-51.
22. TURNER J, DOCKRELL HM: Stimulation of human peripheral blood mononuclear cells with live Mycobacterium bovis BCG activates cytolytic CD8+ T cells in vitro. Immunol 1996; 87:339-342.
23. SMITH SM, MALIN AS, PAULINE T et al: Characterization of human Mycobacterium bovis bacille Calmette-Guerin-reactive CD8+ T cells. Infect Immun 1999; 67:5223-30.
24. MARTINEZ OM, GIBBONS RS, GAROVOY MR, ARONSON FR: IL-4 inhibits IL-2 receptor expression and IL-2 dependant proliferation of human T cells. J Immunol 1990; 144:2211-15.
25. American Thoracic Society. Diagnostic standards and classification of tuberculosis in adults and children. Am J Respir Crit Care Med 2000; 161:1376-95.
26. SILVEIRA HD, ORDWAY D, DOCKRELL H, JACKSON M, VENTURA F: Cell-mediated immune responses to mycobacterial antigens in patients with pulmonary tuberculosis and HIV infection. Clin Exp Immunol 1997; 110:26-34.
27. DLUGOVITSKY D, BAY ML, RATENI L et al: In vitro synthesis of interferon-gamma, interleukin-4, transforming growth factor-beta and interleukin-a beta by peripheral blood mononuclear cells from tuberculosis patients: relationship with severity of pulmonary involvement. Scand J Immunol 1999; 49:210-17.
28. BARNES PF, MODLIN RL: Human cellular immune responses to Mycobacterium tuberculosis. Curr Top Micro Immunol 1996; 215:197-219.
29. TURNER J, CORRAH T, SABBALLY S, WHITTLE H, DOCKRELL HM: A longitudinal study of in vitro IFN gamma production and cytotoxic T cell responses of tuberculosis patients in the gambia. Tuber Lung Dis 2000; 80:161-9.
30. ELLNER JJ, HIRSCH CS, WHALEN CC: Correlates of protective immunity to Mycobacterium tuberculosis in humans. Clin Infest Dis 2000; S3:S279-82.
31. SEAH GT, SCOTT GM, ROOK GAW: Type 2 cytokine gene activation and its relationship to extent of disease in patients with tuberculosis. J Infect Dis 2000; 181:385-89.
32. SEAH GT, ROOK GA: High levels of mRNA encoding IL-4 in unstimulated peripheral blood mononuclear cells from tuberculosis patients revealed by quantitative nested reverse transcriptase-polymerase chain reaction; correlations with serum IgE levels. Scand J Infect Dis 2001; 33:106-9.
33. BAKER RW, WALKER BR, SHAW RJ et al: Increased cortisol:cortisone ratio in acute pulmonary tuberculosis. Am J Respir Crit care Med 2000; 162:1641-7.
34. ROOK G, BAKER R, WALKER B et al: Local regulation of glucocorticoid activity in sites of inflammation. Insights from the study of tuberculosis. Ann N Y Acad Sci 2000; 917:913-22.
35. ROOK GA, SEAH G, USTIANOWSKI A: M. tuberculosis: immunology and vaccination. Eur Respir J 2001; 17:573-57.